Research ArticleEbola virus

Successful Treatment of Ebola Virus–Infected Cynomolgus Macaques with Monoclonal Antibodies

See allHide authors and affiliations

Science Translational Medicine  13 Jun 2012:
Vol. 4, Issue 138, pp. 138ra81
DOI: 10.1126/scitranslmed.3003876

eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. Please read our Terms of Service before submitting your own eLetter.

Compose eLetter

Plain text

  • Plain text
    No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

  • A readily available treament for Ebola

    Intravenous Immunoglobulin (IVIG) obtained from the blood of Ebola Survivors who have cleared the virus (and are free of other viruses too) may provide a temporary treatment for Ebola Virus Disease, until more sophisticated approaches are developed. These IVIG would contain high titers of antibodies targeted to the Ebola Virus. With the consulting help of the pharmaceutical Industry, the armed forces could collect blood f...

    Show More
    Competing Interests: None declared.

Stay Connected to Science Translational Medicine

Navigate This Article